Recombinant Escherichia coli Uncharacterized protein yhdV (yhdV)

Shipped with Ice Packs
In Stock

Description

Production and Biochemical Characteristics

Recombinant YhdV is produced in E. coli with optimized protocols for stability and solubility:

ParameterSpecificationSource
Expression RegionFull-length (1–73 AA)
Purity>90% (determined by SDS-PAGE)
Storage BufferTris/PBS-based buffer, 6% trehalose, pH 8.0
Storage Conditions-20°C/-80°C (long-term); 4°C (working aliquots for ≤1 week)

No enzymatic activity, binding partners, or subcellular localization data are currently available.

Research Context and Functional Hypotheses

YhdV belongs to the broader category of uncharacterized E. coli proteins, which comprise ~15.5% of the genome in EcoCyc . While workflows for identifying transcription factors (TFs) and metabolic regulators have been applied to other uncharacterized proteins (e.g., YiaJ, YdcI, YeiE) , YhdV has not been subjected to systematic functional validation.

Key insights from analogous proteins include:

  • DNA-Binding Proteins: Many uncharacterized E. coli proteins exhibit DNA-binding capabilities, often regulating metabolism or stress responses .

  • Hierarchical Regulation: Uncharacterized TFs frequently target niche pathways (e.g., iron homeostasis, acetate metabolism) rather than global processes .

  • Experimental Challenges: Functional studies require deletion mutants, phenotypic assays, and ChIP-seq to map binding sites .

For YhdV, no such data exist, leaving its role speculative.

Limitations and Future Directions

ChallengeImplicationSource
Lack of Functional DataNo evidence for enzymatic activity, protein interactions, or regulatory roles
Limited Biochemical DataNo structural studies (e.g., X-ray crystallography) or binding assays
Annotation GapsConflicting classifications: "Uncharacterized" in EcoCyc vs. "y-ome" in other studies

Future research should prioritize:

  1. Genetic Deletion Studies: Assess phenotypic changes in yhdV mutants under stress or nutrient-limited conditions.

  2. Proteomic Interactions: Identify binding partners via co-IP or affinity purification.

  3. Structural Analysis: Solve the 3D structure to predict functional domains.

References

  1. Structural and Production Data:

  2. Uncharacterized Protein Workflows:

  3. Classification Challenges:

Product Specs

Form
Lyophilized powder
Note: We prioritize shipping the format we have in stock. However, if you have specific format requirements, please indicate them in your order notes, and we will accommodate your request.
Lead Time
Delivery time may vary depending on the purchasing method and location. Please consult your local distributor for specific delivery timelines.
Note: All our proteins are shipped with standard blue ice packs. If you require dry ice shipping, please inform us in advance, as additional charges may apply.
Notes
Repeated freezing and thawing is not recommended. For optimal results, store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly before opening to ensure the contents settle to the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%. Customers may use this as a reference.
Shelf Life
Shelf life is influenced by various factors, including storage conditions, buffer composition, temperature, and the inherent stability of the protein.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type will be determined during production. If you have a specific tag type preference, please inform us, and we will prioritize developing it accordingly.
Synonyms
yhdV; b3267; JW3235; Uncharacterized protein YhdV
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-73
Protein Length
full length protein
Species
Escherichia coli (strain K12)
Target Names
yhdV
Target Protein Sequence
MKRLIPVALLTALLAGCAHDSPCVPVYDDQGRLVHTNTCMKGTTQDNWETAGAIAGGAAA VAGLTMGIIALSK
Uniprot No.

Target Background

Database Links
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is the yhdV protein in Escherichia coli and why study it?

The yhdV protein in Escherichia coli is classified as an uncharacterized protein with no experimentally validated function. Studying uncharacterized proteins like yhdV is crucial for completing our understanding of bacterial proteomes. According to recent proteome analysis efforts, approximately 6% of detected proteins in well-studied organisms remain functionally uncharacterized, down from 13% just a few years ago . The yhdV protein represents an opportunity to discover novel biochemical functions, regulatory mechanisms, or structural motifs that may have broader implications for understanding bacterial physiology or developing new biotechnological applications.

What is currently known about the structure and basic properties of yhdV?

While specific data on yhdV is limited in the available literature, uncharacterized proteins in E. coli are typically approached through computational predictions of physical and chemical properties. Preliminary analyses of uncharacterized E. coli proteins generally include predictions of:

  • Molecular weight (typically 20-60 kDa for most bacterial proteins)

  • Isoelectric point (useful for purification strategy design)

  • Secondary structure elements (predicted through bioinformatics tools)

  • Presence of conserved domains or motifs

  • Potential transmembrane regions or signal peptides

These predictions serve as starting points for experimental validation. Similar to other E. coli proteins, recombinant yhdV likely has specific solubility characteristics and structural features that would influence experimental approaches for its study .

How can researchers predict potential functions of yhdV?

Predicting functions of uncharacterized proteins like yhdV involves multiple complementary approaches:

  • Sequence homology analysis with proteins of known function

  • Structural prediction and comparison with characterized proteins

  • Genomic context analysis (examination of neighboring genes)

  • Protein-protein interaction predictions

  • Integration of transcriptomic data to identify co-expressed genes

Recent advances in machine learning have enhanced the ability to predict protein functions from sequence data alone. The integration of these computational predictions with experimental data is essential for robust functional annotation . Current initiatives like those described in the "Deciphering the Proteome of Escherichia coli K-12" project utilize machine learning approaches to annotate hypothetical proteins similar to yhdV by integrating transcriptomics data with other computational methods .

What expression systems are most suitable for producing recombinant yhdV protein?

Selection of an appropriate expression system is critical for successful recombinant protein production. For E. coli proteins like yhdV, homologous expression (expression in E. coli itself) is typically the first approach.

The choice of expression system should consider:

Promoter strength: Research comparing T7, lac, tac, and BAD promoters has shown that higher promoter strength does not always yield better results for protein solubility. For uncharacterized proteins like yhdV, testing multiple promoter systems is recommended .

Plasmid copy number: Balance between plasmid copy number and promoter strength is crucial. High copy number plasmids (pMB1-based) combined with strong promoters may lead to inclusion body formation, while low copy number plasmids (p15A-based) may provide better soluble protein yields .

Strain selection: E. coli BL21(DE3) is commonly used for recombinant protein expression due to its reduced protease activity. For proteins showing toxicity or inclusion body formation, specialized strains with metabolic adaptations may be beneficial. For example, strains with ackA mutations have shown improved recombinant protein production due to reduced acetate accumulation .

Carbon source consideration: The choice between glucose and glycerol can significantly impact recombinant protein yields. Glycerol often leads to improved protein solubility compared to glucose due to reduced growth rate and metabolic burden .

What are the optimal induction parameters for recombinant yhdV expression?

Based on studies with similar recombinant proteins in E. coli, the following induction parameters typically yield good results:

  • IPTG concentration: 0.4-1.0 mM for T7-based systems, with 0.4 mM often being sufficient

  • Induction temperature: 25-30°C for improved solubility versus standard 37°C growth

  • Induction duration: 4-16 hours, with shorter times at higher temperatures

  • Induction point: Mid-log phase (OD600 of 0.6-0.8) typically provides optimal balance between cell density and protein expression capacity

For auto-induction systems using lactose as inducer, careful media formulation is required to balance growth and induction phases . For uncharacterized proteins like yhdV, a matrix of expression conditions should be tested to identify optimal parameters.

How can researchers improve solubility of recombinant yhdV protein?

Improving solubility of uncharacterized proteins is a common challenge. For yhdV, consider these strategies:

  • Fusion partners: Addition of solubility enhancers such as MBP, SUMO, or Thioredoxin

  • Co-expression with chaperones: GroEL/GroES, DnaK/DnaJ/GrpE systems to assist folding

  • Reduced expression rate: Lower temperature (16-25°C) and reduced inducer concentration

  • Media optimization: Supplementation with osmolytes or specific amino acids

  • pH optimization: Testing expression at different pH values around the predicted isoelectric point of the protein

The formation of insoluble aggregates is a common obstacle when expressing recombinant proteins. As seen with hepatitis A virus proteins expressed in E. coli, approaches to improve solubility include careful selection of pH relative to the protein's isoelectric point. For partially soluble proteins with pI values around 6.45, buffer systems maintaining pH above this value may improve solubility .

What purification strategies work best for recombinant yhdV protein?

The purification strategy for recombinant yhdV should be designed based on its predicted properties and the expression system used.

For histidine-tagged recombinant proteins:

  • IMAC (Immobilized Metal Affinity Chromatography): Primary purification step using Ni-NTA or Co-NTA resins

  • Size exclusion chromatography: Secondary purification to remove aggregates and obtain homogeneous protein

  • Ion exchange chromatography: Additional purification based on predicted isoelectric point

The following table summarizes purification considerations for recombinant yhdV protein:

PropertyConsiderationRecommended Approach
SolubilityPartially soluble proteins require careful buffer selectionInclude mild detergents or stabilizing agents in lysis buffer
StabilityUnknown stability characteristicsInclude protease inhibitors and maintain 4°C throughout purification
Tag locationImpact on protein folding and functionTest both N- and C-terminal tag placements
Tag removalMay be necessary for functional studiesInclude protease cleavage site between tag and protein
HomogeneityTarget >90% homogeneity for structural studiesMulti-step purification process with final polishing step

As demonstrated in studies with other recombinant proteins, achieving suitable homogeneity (>50%) is critical for downstream applications .

How can researchers verify the identity and integrity of purified yhdV protein?

Verification of recombinant yhdV protein should include:

  • SDS-PAGE analysis: To confirm molecular weight and purity

  • Western blotting: Using anti-His antibodies (for His-tagged constructs)

  • Mass spectrometry analysis: For precise molecular weight determination and peptide mapping

  • N-terminal sequencing: To confirm protein identity and integrity

  • Dynamic light scattering: To assess homogeneity and aggregation state

Mass spectrometry approaches should be configured with appropriate mass tolerances (typically 10 ppm for precursors and 0.5 Da for fragments) with carbamidomethylation of cysteine residues set as fixed modifications and oxidation of methionine as variable modifications .

What analytical methods are recommended for studying yhdV structure?

For structural characterization of uncharacterized proteins like yhdV, a multi-technique approach is recommended:

  • Circular dichroism (CD): For secondary structure assessment

  • Fluorescence spectroscopy: To examine tertiary structure and folding state

  • Limited proteolysis: To identify stable domains and flexible regions

  • Thermal shift assays: To assess stability and identify stabilizing conditions

  • X-ray crystallography or cryo-EM: For high-resolution structural determination if suitable crystals can be obtained

The choice of methods should be guided by the specific questions being addressed and the amount and purity of protein available.

How can transcriptomics data help annotate the function of yhdV?

Transcriptomics data provides valuable insights into gene expression patterns that can help predict protein function:

  • Co-expression analysis: Identifying genes with similar expression patterns as yhdV may suggest functional relationships or pathway involvement

  • Expression under stress conditions: Examining how yhdV expression changes under different stresses can suggest physiological roles

  • Integration with regulon data: Identifying potential regulatory mechanisms controlling yhdV expression

Recent approaches integrating transcriptomics with machine learning have shown success in annotating hypothetical proteins in E. coli K-12, as demonstrated in recent research focused on deciphering the E. coli proteome . These approaches can identify potential functions based on expression patterns shared with characterized proteins.

What experimental approaches can validate predicted functions of yhdV?

Validating predicted functions requires multiple complementary approaches:

  • Gene knockout studies: Assessing phenotypic changes in ΔyhdV strains under various conditions

  • Protein-protein interaction studies: Using pull-down assays, bacterial two-hybrid systems, or co-immunoprecipitation

  • Enzymatic activity assays: Based on predicted functions, design assays to test specific biochemical activities

  • Localization studies: Using fluorescent protein fusions to determine subcellular localization

  • Complementation studies: Testing if yhdV can complement known mutants in related pathways

Each approach provides different lines of evidence that, when combined, can build a comprehensive understanding of protein function.

How can researchers study the physiological role of yhdV using systems biology approaches?

Systems biology approaches offer powerful tools for understanding uncharacterized proteins in their cellular context:

  • Metabolomics analysis: Compare metabolite profiles between wild-type and ΔyhdV strains

  • Flux balance analysis: Model metabolic impacts of yhdV activity based on predicted functions

  • Network analysis: Place yhdV in protein-protein interaction or metabolic networks

  • Multi-omics integration: Combine proteomics, transcriptomics, and metabolomics data

  • Condition-specific experiments: Test function under specific stress conditions or growth phases

These approaches are particularly valuable for proteins like yhdV where direct functional assays may not be immediately obvious.

How can researchers address inclusion body formation when expressing yhdV?

Inclusion body formation is a common challenge when expressing recombinant proteins in E. coli. For yhdV, consider:

  • Refolding protocols: If inclusion bodies are unavoidable, develop refolding protocols using step-wise dialysis or on-column refolding

  • Solubilization agents: Optimize concentrations of urea or guanidine hydrochloride for initial solubilization

  • Redox control: Manage disulfide bond formation through optimized ratios of reduced/oxidized glutathione

  • Additive screening: Test various additives (L-arginine, sucrose, glycerol) to improve refolding efficiency

  • Partial solubilization: For proteins with partial solubility like some recombinant viral proteins, buffer optimization around the isoelectric point can improve native extraction

While refolding from inclusion bodies is challenging, it can sometimes provide higher yields of purified protein than direct soluble expression.

What strategies can address low expression levels of yhdV?

Low expression levels may be addressed through:

  • Codon optimization: Adjust codons to match E. coli preference, especially for rare codons

  • Promoter selection: Test multiple promoter systems beyond T7, including tac, trc and BAD promoters

  • Strain selection: E. coli strains with ackA mutations have shown increased recombinant protein production

  • Media optimization: Rich media formulations with optimized carbon sources

  • Vector backbone selection: Balance between copy number and expression level

For challenging proteins, a systematic analysis of vector design elements including promoter strength and plasmid copy number is essential, as demonstrated in studies comparing different expression systems for recombinant protein production in E. coli .

How can researchers design experiments to examine potential protein-protein interactions involving yhdV?

To investigate protein-protein interactions:

  • Bacterial two-hybrid screening: Identify potential interacting partners

  • Pull-down assays: Using tagged yhdV as bait to capture interacting proteins

  • Surface plasmon resonance: Quantify interaction kinetics with predicted partners

  • Crosslinking studies: Chemical crosslinking followed by mass spectrometry to identify proximity-based interactions

  • Co-immunoprecipitation: Using antibodies against yhdV or potential partners

Each method has strengths and limitations, so combining multiple approaches provides stronger evidence for specific interactions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.